Molecular radiotheranostics for neuroendocrine tumours
Shaunak Navalkissoor, Glenn Flux and Jamshed Bomanji
DOI: https://doi.org/10.7861/clinmedicine.17-5-462
Clin Med October 2017 Shaunak Navalkissoor
ARoyal Free London NHS Foundation Trust, London, UK
Roles: consultant in nuclear medicine
Glenn Flux
BRoyal Marsden Hospital & Institute of Cancer Research, London, UK
Roles: head of radio-isotope physics
Jamshed Bomanji
CUniversity College London Hospitals NHS Foundation Trust, London, UK
Roles: professor and head of clinical nuclear medicine
Article Information
vol. 17 no. 5 462-468
PubMed:
Published By:
Print ISSN:
Online ISSN:
History:
- Published online October 3, 2017.
Copyright & Usage:
© Royal College of Physicians 2017. All rights reserved.
Author Information
- Shaunak Navalkissoor, consultant in nuclear medicineA⇑,
- Glenn Flux, head of radio-isotope physicsB and
- Jamshed Bomanji, professor and head of clinical nuclear medicineC
- ARoyal Free London NHS Foundation Trust, London, UK
- BRoyal Marsden Hospital & Institute of Cancer Research, London, UK
- CUniversity College London Hospitals NHS Foundation Trust, London, UK
- Address for correspondence: Dr Shaunak Navalkissoor, Department of Nuclear Medicine, Royal Free London NHS Foundation Trust, Pond Street, Hampstead, London NW3 2QG, UK.Email: s.navalkissoor{at}nhs.net
Article usage
Article Tools
Molecular radiotheranostics for neuroendocrine tumours
Shaunak Navalkissoor, Glenn Flux, Jamshed Bomanji
Clinical Medicine Oct 2017, 17 (5) 462-468; DOI: 10.7861/clinmedicine.17-5-462
Citation Manager Formats
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.